Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center

被引:3
|
作者
Miller, Kenneth [1 ]
Mehta, Rutika [2 ]
Abraham, Joseph [3 ]
Opneja, Aman [2 ]
Jain, Rohit K. [2 ]
机构
[1] Sinai Hosp Baltimore, Div Hematol Oncol, Baltimore, MD USA
[2] Sinai Hosp Baltimore, Dept Internal Med, Baltimore, MD USA
[3] Apex Epidemiol, Baltimore, MD USA
关键词
cancer survivor; surveillance; gaps in care; BREAST-CANCER; ONCOLOGISTS; PHYSICIAN; POPULATION; ATTITUDES; QUALITY; SEASONS; WILL;
D O I
10.1097/COC.0000000000000217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The majority of the cancer survivors in the United States are 5 or more years beyond their diagnosis. The follow-up care of these individuals remains a major concern for survivors and for the cancer care system. The purpose of this study was to characterize long-term cancer survivors' visits at a National Cancer Institute-designated comprehensive cancer center. Materials and Methods: We abstracted electronic medical record data for 18,882 unique patients' visits during 2010 to determine the distribution of the number of years of survival after the initial cancer diagnosis. We then reviewed 374 patient visits during a randomly selected week in April 2010 to determine whether patients were seen for treatment of a new diagnosis of cancer, a residual or recurrent cancer, for a second or secondary cancer, or for cancer survivorship care while not actively receiving treatment (other than adjuvant hormonal therapy). Results: In the 1-year group of 18,882 unique patients visits the percentage of patients who were <1, 1 to 5, 6 to 10, and >10 years postdiagnosis were 18.7%, 48.7%, 18.9%, and 13.8%, respectively. During the selected week, 74% of the total office visits were with patients who were being actively treated for a new cancer, relapse, or a second cancer, whereas 24% were not being seen for treatment of an active malignancy. The percentage of total office visits with patients who were <6, 6 to 10, or >10 years postdiagnosis and had completed their initial treatment were 21.4%, 3.7%, and 1%, respectively. Approximately 5% of oncology office visits were with cancer survivors who were 5 or more years postdiagnosis and not receiving treatment. Conclusions: In a database of over 18,000 unique patients who were seen at a major cancer center in 2010, approximately 68% were 5 or less and 32% were 6 or more years postdiagnosis. A review of the medical oncology notes in a random sample of cases of oncology visits demonstrated that approximately 5% of office visits were with long-term cancer survivors who were >5 years postdiagnosis and not receiving active treatment. Implications for Cancer Survivors: Cancer survivors often indicate a preference to receive long-term follow-up care from their oncologist. These findings suggest that long-term cancer survivorship care represents only a small component of care at a comprehensive cancer center and also that alternative models for long-term survivorship health care need to be considered.
引用
收藏
页码:639 / 643
页数:5
相关论文
共 50 条
  • [41] Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers
    Si-Yuan Wu
    John Terrell
    Anne Park
    Nancy Perrier
    [J]. World Journal of Surgery, 2020, 44 : 385 - 392
  • [42] Most National Cancer Institute-Designated Cancer Center Websites Do Not Provide Survivors with Information About Cancer Rehabilitation Services
    Julie K. Silver
    Vishwa S. Raj
    Jack B. Fu
    Eric M. Wisotzky
    Sean Robinson Smith
    Sasha E. Knowlton
    Alexander J. Silver
    [J]. Journal of Cancer Education, 2018, 33 : 947 - 953
  • [43] Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center
    Furlan, Julio C.
    Furlan, Daniel T.
    Marquez-Chin, Cesar
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (02) : 184 - 190
  • [44] Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers
    Wu, Si-Yuan
    Terrell, John
    Park, Anne
    Perrier, Nancy
    [J]. WORLD JOURNAL OF SURGERY, 2020, 44 (02) : 385 - 392
  • [45] What Factors Influence Minority Use of National Cancer Institute-Designated Cancer Centers?
    Huang, Lyen C.
    Ma, Yifei
    Ngo, Justine V.
    Rhoads, Kim F.
    [J]. CANCER, 2014, 120 (03) : 399 - 407
  • [46] Consensus Building to Identify Nursing Research Priorities Among Oncology Nurses: A Delphi Study in a National Cancer Institute-Designated Comprehensive Cancer Center
    Hacker, Eileen Danaher
    Forbes, Sheryl
    Martinez, Ashley
    Fadol, Anecita
    Vaughn, Jessica
    Shelton, Valerie
    Dains, Joyce
    [J]. CANCER NURSING, 2024,
  • [47] National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer
    Schabath, Matthew B.
    Blackburn, Catherine A.
    Sutter, Megan E.
    Kanetsky, Peter A.
    Vadaparampil, Susan T.
    Simmons, Vani N.
    Sanchez, Julian A.
    Sutton, Steven K.
    Quinn, Gwendolyn P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07) : 547 - +
  • [48] Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers
    Prindiville, Sheila A.
    Sarosy, Gisele A.
    Loose, David
    Ciolino, Henry
    Doroshow, James H.
    [J]. CANCER JOURNAL, 2022, 28 (02): : 111 - 117
  • [49] Case-Linked Analysis of Clinical Trial Enrollment Among Adolescents and Young Adults at a National Cancer Institute-Designated Comprehensive Cancer Center
    Collins, Chelsea L.
    Malvar, Jemily
    Hamilton, Ann S.
    Deapen, Dennis M.
    Freyer, David R.
    [J]. CANCER, 2015, 121 (24) : 4398 - 4406
  • [50] Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers
    de Moor, Janet S.
    Mollica, Michelle
    Sampson, Annie
    Adjei, Brenda
    Weaver, Sallie J.
    Geiger, Ann M.
    Kramer, Barnett S.
    Grenen, Emily
    Miscally, Memi
    Ciolino, Henry P.
    [J]. JNCI CANCER SPECTRUM, 2021, 5 (03)